Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Targeted partial reprogramming of age-associated cell states improves markers of health in mouse models of aging

ABSTRACT: Targeted partial reprogramming of age-associated cell states improves markers of health in mouse models of aging

PROVIDER: PRJNA832732 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18939705.fastq.gz	Fastqsanger.gz
	SRR18939706.fastq.gz	Fastqsanger.gz
	SRR18939707.fastq.gz	Fastqsanger.gz
	SRR18939708.fastq.gz	Fastqsanger.gz
	SRR18939709.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 65

Similar Datasets

Targeted partial reprogramming of age-associated cell states improves markers of health in mouse models of aging

Project description:The study aims to explore the effects of CDKN2A-OSK expression across various tissues and human primary cells using next-generation sequencing. Mouse tissues and human cultured cells were collected at specific time points, followed by RNA extraction and next-generation sequencing. The sequencing data for mouse RNA were aligned to the mm9 genome, while the human RNA data were aligned to the Hg38 genome using standard RNA alignment and analysis protocols.

2024-11-12 | GSE201710 | GEO

Partial replacement of glucose with galactose in the post-weaning diet positively affects markers of liver health

Project description:Partial replacement of glucose with galactose in the post-weaning diet positively affects markers of liver health

| PRJNA514332 | ENA

Integration of genomic and transcriptomic markers improves the prognosis prediction of acute promyelocytic leukemia

Project description:Integration of genomic and transcriptomic markers improves the prognosis prediction of acute promyelocytic leukemia

| PRJNA721935 | ENA

Mitochondria-targeted partial inhibiton of complex I increase health and lifespan in mice.

Project description:Mitochondria-targeted partial inhibiton of complex I increase health and lifespan in mice.

| PRJNA675089 | ENA

Oral JAK/SYK-inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in atopic dermatitis

Project description:Oral JAK/SYK-inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in atopic dermatitis

| PRJNA551301 | ENA

FVB Partial Co1

Project description:FVB Partial Co1

| PRJEB13645 | ENA

Ginkgolide B administration improves health span and lifespan in aged mice

Project description:Ginkgolide B (GB) is a small molecule from Ginkgo biloba and implicates the reduction of certain aging-related morbidities; however, whether GB improves overall healthspan and longevity remains unknown. By single-nucleus RNA sequencing (snRNA-seq), we revealed that GB partially restored the aging-related dysregulation in cell-type composition, intracellular signaling pathways, and cell-cell communication in skeletal muscle. Notably, GB reduced the quantity of aging-induced novel Runx1+ type 2B myonuclei, which are particularly associated with an apoptotic burden and aging-related signatures.

2024-10-31 | GSE218027 | GEO

In vivo partial reprogramming alters manifestation of age-associated molecular changes in aging mice (7 months; long-term treatment)

Project description:Various length of in vivo 4F (four Yamanaka factors) partial reprogramming protocols were performed to evaluate effects of longer-term partial reprogramming in physiologically aging wild-type mice. Here, long-term (7 months) partial reprogramming was induced and transcriptional changes in various tissues were compared to age-matched, untreated mice.

2022-01-11 | GSE190983 | GEO

In vivo partial reprogramming alters manifestation of age-associated molecular changes in aging mice (10 months; long-term treatment)

Project description:Various length of in vivo 4F (four Yamanaka factors) partial reprogramming protocols were performed to evaluate effects of longer-term partial reprogramming in physiologically aging wild-type mice. Here, long-term (10 months) partial reprogramming was induced and transcriptional changes in various tissues were compared to age-matched, untreated mice.

2022-01-11 | GSE190985 | GEO

In vivo partial reprogramming alters manifestation of age-associated molecular changes in aging mice (1 months; sort-term treatment)

Project description:Various length of in vivo 4F (four Yamanaka factors) partial reprogramming protocols were performed to evaluate effects of longer-term partial reprogramming in physiologically aging wild-type mice. Here, short-term (1 months) partial reprogramming was induced and transcriptional changes in various tissues were compared to age-matched, untreated mice.

2022-01-11 | GSE190984 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data